Researchers from the University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) have discovered a unique nano-scaled DNA signature that appears to be common to all cancers.
Research led by Professor Gordon Xu of the Australian Institute for Bioengineering and Nanotechnology (AIBN) has shown that clay nanoparticles can significantly boost immune responses as vaccine adjuvants.
Researchers have developed a new approach to delivering DNA into cells using spikey silica nanoparticles. These nanoparticles transport the genetic cargo across the cell wall while protecting it from degradation.
Trau group researchers are using nanotechnology for fabrication-free disease biomarker detection within a fluidic droplet. The “lab-in-a-drop” system can be extremely useful for the detection of disease nucleic acid biomarkers.